House Committee holds hearings on sky-rocketing price for children's allergy medicine
Mylan Inc. CEO Heather Bresch holds up a sample of the company's two-pack EpiPen as she testifies before the House Oversight and Government Reform Committee, on Capitol Hill in Washington, DC, September 21, 2016. The committee is investigating the sky-rocketing price of the life-saving children's allergy medicine. Photo by Mike Theiler/UPI
Please fill out form for pricing information for the photo below.